How Will AbbVie's Neuroscience Franchise Perform in Q2 Earnings?

• click to rate

  Posted by Two Blokes Jul 22 - Filed in Stock - 9 views
  
  ABBV's neuroscience sales are projected to jump 15% in Q2, driven by Botox Therapeutic, Vraylar and oral migraine drug gains.